TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) and Novozymes Biopharma DK A/S (hereinafter referred to as Novozymes) reached a basic agreement today on the supply of recombinant human serum albumin as described below:
TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) and Novozymes Biopharma DK A/S (hereinafter referred to as Novozymes) reached a basic agreement today on the supply of recombinant human serum albumin as described below:
